B Vitamins May Benefit Ocular Health

Article

B vitamins may help prevent age-related macular degeneration in older women, according to The Women's Antioxidant and Folic Acid Cardiovascular Study, the first rigorous study of its kind, published in the Feb. 23 edition of Archives of Internal Medicine (2009;169:335-341).

Key Points

Chicago-B vitamins may help prevent age-related macular degeneration (AMD) in older women, according to The Women's Antioxidant and Folic Acid Cardiovascular Study, the first rigorous study of its kind, published in the Feb. 23 edition of Archives of Internal Medicine (2009;169:335-341).

"Other than avoiding cigarette smoking, this is the first suggestion from a randomized trial of a possible way to reduce early stage AMD," said William Christen, ScD, of Brigham and Women's Hospital, Boston, who led the research. Dr. Christen said the findings should apply to men as well.

The study included more than 5,000 women aged 40 years and older who were at risk for development of cardiovascular disease. The participants who were randomized to a combination of B vitamins, i.e., B-6, folic acid and B-12, reduced their risk of AMD by more than one-third after 7 years compared with those who took placebo. Among the women randomized to the B vitamins, 55 cases of AMD developed compared with 82 cases in the placebo group. In the B vitamin group, 26 cases caused substantial vision loss, compared with 44 such cases among those randomized to placebo. However, Dr. Christen pointed out that small number of cases of late-stage AMD did not allow definitive claims about the potential benefit of the B vitamins.

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.